Cancer: Too Much Information

We're lucky we live close to two research centers

This is troubling but not surprising: many oncologists can't stay abreast of new developments in cancer research. [bold added]

Cancer care is getting more complicated, thanks to a better understanding of cancer’s molecular underpinnings. Doctors now think of cancer as more than 100 distinct diseases, with cancers including lung, breast and bladder broken into subtypes.

That complexity is contributing to a divide in how patients fare depending on where they go.

Oncologists at magnet cancer centers that dot the U.S. develop expertise in just a few cancer subtypes. They draw from a rapidly expanding arsenal of new drugs for specific and sometimes rare cancers, including experimental ones that aren’t widely available.

But most people get treated locally to be near home and jobs. Local oncologists, faced with a range of cancers, can’t stay up-to-date on everything. The National Comprehensive Cancer Network updated its nearly 90 guidelines across cancer types more than 200 times in the past year.

A third of 120 patients who sought a second opinion at Memorial Sloan Kettering Cancer Center in New York had their treatment changed, a 2023 review found. MD Anderson Cancer Center in Houston said about one in five of its new patients are rediagnosed or restaged. Patients at academic centers have better outcomes for cancers including lung and multiple myeloma, studies show.

“It’s possible that one out of five patients in America is getting the wrong treatment,” said Dr. Peter WT Pisters, MD Anderson’s president.

I don't fault oncologists for finding it hard to do keep up with the research while treating patients by day. This is one obvious application for artificial intelligence, i.e., sifting through haystacks of information to find the needle that may apply to a patient.

Meanwhile, it behooves us all to stay alive as long as possible to give us the best chance for the science to cure the diseases that might kill us.